RxDoctor Payments Data

Mary Browning

Physician Assistant · Gainesville, FLNPI 1144740283

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $11,450 of the $18,522 with a category attached, or 61.8%. Johnson & Johnson accounts for 89.6% of it on its own, with 17 other manufacturers making up the rest. 2025 is the largest year on record at $9,191, more than ten times the $241 reported in 2021. Among physician assistant clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,522in general payments, 2019–2025

Across 117 payments — averaging $158.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$17K
  • AbbVie$603
  • Tris Pharma Inc$343
  • AstraZeneca$117
  • Gilead$113
  • Neurocrine Biosciences, Inc.$109
  • plus $646 from 12 others

What the payments were for

  • Speaking & faculty fees$11,45062%
  • Travel & lodging$3,40618%
  • Food & beverage$3,66620%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,522 in reported general payments places this provider in the 95th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida →

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole12$20,423
SpravatoEsketamine Hcl11$18,491
Quetiapine Fumarate53$925
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine14$835
Temazepam11$726
Hydroxyzine Hcl33$697
Prazosin Hcl22$357
Bupropion Hcl SrBupropion Hcl11$309
Mirtazapine22$304
Desvenlafaxine Succinate ErDesvenlafaxine Succinate12$289
Aripiprazole15$257
Gabapentin15$226
Bupropion XlBupropion Hcl14$224
Trazodone Hcl54$175
Clonazepam33$154

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$21$20,42312 claims
Johnson & JohnsonSpravato$16,591$18,49111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Gainesville

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →